Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Attention Deficit Hyperactivity Disorder
Analysis of treatment highlights gender differences in ADHD patients
June 23rd, 2005
Females with attention deficit hyperactivity disorder (ADHD) and treated with atomoxetine HCl showed no difference in core ADHD symptom improvement compared to men, yet women displayed greater emotional symptom improvement when treated. The data is according to a retrospective analysis of two studies presented at the 158th Annual Meeting of the American Psychiatric Association. Atomoxetine is approved for the treatment of adult ADHD. At the start of the study, females displayed greater core ADHD symptoms (e.g., disorganization, inattention, and impulsivity) than males and showed no difference in symptom improvement over males at the end of the study...
Source: Women's Health Weekly (2005-06-23)
|
